Vol. 10, No. 4
December, 2000
Winthrop Ranked #1 in Metropolitan Region for Open-Heart Surgery
Telemetry Monitoring Units Safeguard Cardiac Patients
Cardiac Rehabilitation Program Certified
Uterine Artery Embolization:
A Non-Surgical Approach to Fibroid Tumors
Osteoporosis Studies Recruit Women
Senator Balboni Sponsors Grant for Neonatal Transport System
Re-Opening of Expanded Pulmonary Rehabilitation Unit
Respiratory Syncytial Virus Trials Focus on Children
Combating Tickborne Infectious Diseases
Warding off the Flu
Arabian Nights Gala Benefits Hospital
Changes to Winthrop’s Board of Directors
New Members Elected to Winthrop’s Board of Directors
Winthrop Directors Cut Ribbon at New Hospital Entrance
Senior Volunteer Awards
Luncheon
In appreciation of our devoted volunteers
New Name For The Long Island Poison Control Center
Winthrop Hosts Child Health Plus
Open Enrollment
VALENTINE’S DAY PARTY FOR KIDS
Copyright
Back to Publications
|
Sidney Glanz, MD, Chief, Interventional Radiology with the Department of Radiology at Winthrop
|
 terine artery embolization is a relatively new
procedure used as a non-surgical alternative to treat benign tumors of the uterus, also known as fibroids,” said Sidney Glanz, MD, Chief, Interventional Radiology with the Department of Radiology at Winthrop. Dr. Glanz performs the procedure in the Hospital’s new Interventional Radiology Suite.
“One of the characteristics of these benign tumors is that they require an abnormally large blood supply,” explained Dr. Glanz. “In this procedure, we significantly reduce the blood supply to the uterus, thereby diminishing blood supply to the tumor.”
Fibroids can affect women of any age, and result in pain and excessive bleeding. By restricting blood flow to the area, uterine artery embolization shrinks the tumor, which in turn lessens pain
and bleeding.
At Winthrop, the procedure is performed on a one-day hospital stay basis, meaning that women typically remain in the hospital for a total of 23 hours. “This enables us to effectively control pain and discomfort following the procedure,” said Dr. Glanz.
“As an alternative to hysterectomy or surgical removal of the fibroids, uterine artery embolization appears to be an extremely effective technique,” said Dr. Glanz. “Because our results over the past two years have been so positive, the procedure is now being considered as a possible treatment for women who would like to preserve their fertility.”
For additional information, call (516) 663-2452.
Osteoporosis Studies Recruit Women
 he Bone Mineral Research Center at Winthrop announced a new clinical trial of a self-injectable osteoporosis medication. Post-menopausal women, previously diagnosed with
osteoporosis, who have suffered a fracture, are urged to participate.
They must be willing to commit themselves to the protocol time period, during
which they will be monitored through bone density testing, physical examinations, and laboratory tests.
John F. Aloia, MD, Chief Academic Officer at Winthrop, an
internationally recognized expert in osteoporosis, is conducting the
clinical trials, which are coordinated by Jane Moore, RN, MSN, CCRC, Nurse Specialist.
Medically appropriate women are invited to call Ms. Moore at (516) 663-2772 for more information.
|
